New Cancer Trial in Cork Seen as a Positive Advancement

The Melody trial in Cork, involving routine blood tests to identify genetic markers, has been welcomed as a positive development in cancer research. Aislinn Higgins, a 48-year-old participant in the patient advisory group, has been involved in shaping the trial. This initiative represents a step forward in personalized cancer treatment approaches.

Originally published by gnews